| Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease YI Duan, C Llorente, S Lang, K Brandl, H Chu, LU Jiang, RC White, ... Nature 575 (7783), 505-511, 2019 | 567 | 2019 |
| Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease H Chu, Y Duan, L Yang, B Schnabl Gut 68 (2), 359-370, 2019 | 280 | 2019 |
| Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice T Hendrikx, YI Duan, Y Wang, JH Oh, LM Alexander, W Huang, P Stärkel, ... Gut 68 (8), 1504-1515, 2019 | 228 | 2019 |
| Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis S Lang, Y Duan, J Liu, MG Torralba, C Kuelbs, M Ventura‐Cots, ... Hepatology 71 (2), 522-538, 2020 | 168 | 2020 |
| Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma Q Zhang, C Ma, Y Duan, B Heinrich, U Rosato, LP Diggs, L Ma, S Roy, ... Cancer discovery 11 (5), 1248-1267, 2021 | 140 | 2021 |
| The Candida Albicans Exotoxin Candidalysin Promotes Alcohol‐Associated Liver Disease H Chu, Y Duan, S Lang, L Jiang, Y Wang, C Llorente, J Liu, S Mogavero, ... Journal of Hepatology 72 (3), 391-400, 2019 | 139 | 2019 |
| Intestinal virome signature associated with severity of nonalcoholic fatty liver disease S Lang, M Demir, A Martin, LU Jiang, X Zhang, YI Duan, B Gao, ... Gastroenterology 159 (5), 1839-1852, 2020 | 117 | 2020 |
| Intestinal virome in patients with alcoholic hepatitis L Jiang, S Lang, Y Duan, X Zhang, B Gao, J Chopyk, LK Schwanemann, ... Hepatology 72 (6), 2182-2196, 2020 | 85 | 2020 |
| The fecal mycobiome in non-alcoholic fatty liver disease M Demir, S Lang, P Hartmann, Y Duan, A Martin, Y Miyamoto, ... Journal of Hepatology 76 (4), 788-799, 2022 | 80 | 2022 |
| Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients S Lang, B Fairfied, B Gao, Y Duan, X Zhang, DE Fouts, B Schnabl Gut microbes 12 (1), 1785251, 2020 | 62 | 2020 |
| Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either P Hartmann, H Chu, Y Duan, B Schnabl American Journal of Physiology-Gastrointestinal and Liver Physiology, 2019 | 62 | 2019 |
| Bacteriophages and their potential for treatment of gastrointestinal diseases Y Duan, R Young, B Schnabl Nature reviews Gastroenterology & hepatology 19 (2), 135-144, 2022 | 52 | 2022 |
| Dynamic changes of the fungal microbiome in alcohol use disorder P Hartmann, S Lang, S Zeng, Y Duan, X Zhang, Y Wang, M Bondareva, ... Frontiers in physiology 12, 699253, 2021 | 47 | 2021 |
| Intestinal virome and therapeutic potential of bacteriophages in liver disease CL Hsu, Y Duan, DE Fouts, B Schnabl Journal of hepatology 75 (6), 1465-1475, 2021 | 35 | 2021 |
| Serum and fecal oxylipins in patients with alcohol-related liver disease B Gao, S Lang, Y Duan, Y Wang, DL Shawcross, A Louvet, P Mathurin, ... Digestive diseases and sciences 64, 1878-1892, 2019 | 34 | 2019 |
| Cytolysin‐positive Enterococcus faecalis is not increased in patients with non‐alcoholic steatohepatitis S Lang, M Demir, Y Duan, A Martin, B Schnabl Liver International 40 (4), 860-865, 2020 | 32 | 2020 |
| Functional microbiomics reveals alterations of the gut microbiome and host co‐metabolism in patients with alcoholic hepatitis B Gao, Y Duan, S Lang, D Barupal, TC Wu, L Valdiviez, B Roberts, ... Hepatology communications 4 (8), 1168-1182, 2020 | 30 | 2020 |
| CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease Y Duan, H Chu, K Brandl, L Jiang, S Zeng, N Meshgin, ... Nature communications 12 (1), 7172, 2021 | 26 | 2021 |
| The DnaA inhibitor SirA acts in the same pathway as Soj (ParA) to facilitate oriC segregation during Bacillus subtilis sporulation Y Duan, JD Huey, JK Herman Molecular microbiology 102 (3), 530-544, 2016 | 20 | 2016 |
| Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice P Hartmann, Y Duan, Y Miyamoto, M Demir, S Lang, E Hasa, P Stern, ... Hepatology international 16 (2), 359-370, 2022 | 19 | 2022 |
Peter StärkelCliniques Universitaires Saint Luc, Université Catholique de LouvainVerified email at uclouvain.be
